RECURRENT OVARIAN CARCINOMA
Clinical trials for RECURRENT OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug combo tested for rare gene mutation – but trial stopped early
Disease control TerminatedThis study tested two drugs, niraparib and bevacizumab, alone or together, in people with recurrent endometrial or ovarian cancer that has a specific gene change called ARID1A. The goal was to see if the drugs could shrink tumors. However, the trial was stopped early after enroll…
Matched conditions: RECURRENT OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Measles virus takes on ovarian cancer in early trial
Disease control TerminatedThis phase 2 trial tested a genetically modified measles virus (MV-NIS) against standard chemotherapy in 17 women with ovarian, fallopian, or peritoneal cancer that no longer responded to platinum drugs. The virus was designed to infect and kill cancer cells while leaving healthy…
Matched conditions: RECURRENT OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC